INS and type 1 diabetes mellitus: Within this technological advance in diabetes, the integration of CGM with insulin pumps has led to the emergence of advanced hybrid closed-loop systems (AHCL), which have achieved a significant improvement in metabolic control and quality of life for both pediatric and adult patients with T1D [7–13].